Reviews
Clinical Management and Practice Variations in Wearable-Detected Atrial Fibrillation
Seegobin et alMethodist DeBakey cardiovascular journal

Consumer-grade wearable devices utilizing photoplethysmography (PPG) and single-lead electrocardiography (ECG) are increasingly deployed to detect irregular rhythms suggestive of atrial fibrillation (AF) in asymptomatic ambulatory individuals. However, rapid technology adoption has outpaced standardized clinical pathways, creating uncertainty regarding how clinicians should evaluate PPG notifications, patient-triggered single-lead ECG tracings, and continuous ambulatory ECG patch recordings.
A systematic review of MEDLINE, the Cochrane Library, and Google Scholar evaluating literature published from January 2015 through December 2025 identified 10 eligible studies: one randomized clinical trial, five prospective or retrospective observational and single-arm studies, and four clinician surveys. Patient-level data showed high actionability of wearable alerts, with 57% to 83.5% of recipients seeking clinical evaluation.
Across patients with alerts subsequently confirmed as AF, direct oral anticoagulation initiation rates exhibited wide disparity, ranging from 12% to 90%. This variation was attributed to differences in baseline population risk, diagnostic confirmation methods, and reporting denominators. Clinician survey findings mirrored this lack of clinical consensus: while 99.5% of physicians required traditional diagnostic confirmation prior to initiating treatment, accepted AF duration thresholds prompting anticoagulation varied from 5 to 6 minutes (reported by 15% of clinicians) to more than 24 hours (reported by 34%). Furthermore, referral patterns diverged across specialties, with emergency medicine physicians more than twice as likely to refer patients to specialists compared with primary care physicians.
To address the guideline-practice gap identified across these studies, the review authors proposed a conceptual clinical pathway requiring prospective validation that couples confirmatory diagnostic evaluation with risk-stratified management.
Key Takeaways
- Direct oral anticoagulant initiation ranged widely from 12% to 90% among patients whose wearable alerts were confirmed as atrial fibrillation, with 57% to 83.5% of alert recipients seeking medical follow-up.
- Although 99.5% of surveyed physicians required traditional diagnostic confirmation before treatment, the atrial fibrillation duration threshold warranting anticoagulation ranged from 5 to 6 minutes (15% of clinicians) to over 24 hours (34%).
- Practice patterns varied by clinician specialty, with emergency medicine physicians more than twice as likely as primary care physicians to refer patients with wearable alerts to a specialist.
Read the original sourceMethodist DeBakey cardiovascular journal
